Sera Prognostics, Inc. (SERA)
2.03
-0.01
(-0.49%)
USD |
NASDAQ |
Oct 23, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Sera Prognostics Enterprise Value : 36.62M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 36.62M |
| October 22, 2026 | 37.01M |
| October 21, 2026 | 36.62M |
| October 20, 2026 | 36.62M |
| October 19, 2026 | 36.62M |
| October 16, 2026 | 37.80M |
| October 15, 2026 | 36.62M |
| October 14, 2026 | 38.19M |
| October 13, 2026 | 37.01M |
| October 12, 2026 | 38.19M |
| October 09, 2026 | 37.01M |
| October 08, 2026 | 36.22M |
| October 07, 2026 | 38.19M |
| October 06, 2026 | 37.40M |
| October 05, 2026 | 35.43M |
| October 02, 2026 | 38.98M |
| October 01, 2026 | 37.01M |
| September 30, 2026 | 38.98M |
| September 29, 2026 | 35.83M |
| September 28, 2026 | 36.22M |
| September 25, 2026 | 37.01M |
| September 24, 2026 | 39.77M |
| September 23, 2026 | 37.80M |
| September 22, 2026 | 40.56M |
| September 21, 2026 | 40.16M |
| Date | Value |
|---|---|
| September 18, 2026 | 38.78M |
| September 17, 2026 | 38.19M |
| September 16, 2026 | 36.22M |
| September 15, 2026 | 35.04M |
| September 14, 2026 | 35.43M |
| September 11, 2026 | 36.62M |
| September 10, 2026 | 37.40M |
| September 09, 2026 | 35.43M |
| September 08, 2026 | 35.83M |
| September 04, 2026 | 36.22M |
| September 03, 2026 | 34.64M |
| September 02, 2026 | 35.83M |
| September 01, 2026 | 38.59M |
| August 31, 2026 | 40.16M |
| August 28, 2026 | 38.19M |
| August 27, 2026 | 36.62M |
| August 26, 2026 | 38.98M |
| August 25, 2026 | 42.53M |
| August 24, 2026 | 42.53M |
| August 21, 2026 | 40.95M |
| August 20, 2026 | 39.38M |
| August 19, 2026 | 35.04M |
| August 18, 2026 | 32.67M |
| August 17, 2026 | 33.46M |
| August 14, 2026 | 33.85M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 651.69M |
| BioRestorative Therapies, Inc. | -1.494M |
| CareDx, Inc. | 3.209B |
| Natera, Inc. | 57.16B |
| Exagen, Inc. | 178.95M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.139M |
| Revenue (Quarterly) | 0.03M |
| Total Expenses (Quarterly) | 9.169M |
| EPS Diluted (Quarterly) | -0.181 |
| Gross Profit Margin (Quarterly) | -606.7% |
| Profit Margin (Quarterly) | -30.46K% |
| Earnings Yield | -32.69% |
| Normalized Earnings Yield | -32.69 |